Viewing nowUnipito Tablet 20 Milligrams (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 201307062 · Approved 2013.04.24 · Insurance code 649506240
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular disease. It lowers the risk of cardiovascular events such as myocardial infarction, stroke, vascular surgery, and angina in adults with multiple risk factors for coronary heart disease or in patients with type 2 diabetes. Additionally, it reduces the risk of hospitalization due to myocardial infarction, stroke, or congestive heart failure in patients who already have coronary heart disease and contributes to the improvement of angina. In patients with hyperlipidemia, it reduces LDL cholesterol and total cholesterol while increasing HDL cholesterol to help regulate blood lipid balance. It is also safely used in pediatric patients with heterozygous familial hypercholesterolemia to effectively lower cholesterol levels. This medication is used to promote cardiovascular health and assist in the management of hyperlipidemia.
Patients taking atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the drug at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at doses ranging from 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks of starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in adult patients.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily.
This medication may cause severe muscle abnormalities; therefore, if symptoms such as muscle pain or weakness occur, usage should be stopped immediately, and a doctor should be consulted. Treatment should be discontinued if severe myopathy or rhabdomyolysis is suspected. Patients with poor kidney function or a history of liver disease should be especially cautious. This medication should not be used in patients who have had allergic reactions, in those with active liver disease, in patients with muscle disorders, pregnant or nursing women, or in children under 10 years of age. Patients with a history of alcohol abuse, liver disease, elderly patients, or those with hypothyroidism, who have a higher risk of muscle abnormalities, require careful examination before administration. This medication may affect liver function; therefore, liver function tests should be conducted regularly before and during treatment. If symptoms of hepatitis (nausea, vomiting, malaise, etc.) occur, the doctor should be notified immediately. Women of childbearing age should use appropriate contraception while taking this medication and discontinue use if pregnancy is confirmed. This medication may interact with several drugs; therefore, patients taking other medications must inform their doctor or pharmacist, especially when using certain antibiotics, antifungals, protease inhibitors, etc. In case of overdose, there is no specific antidote, so patients should go to the hospital immediately for treatment based on symptoms, and liver function and muscle condition should be monitored. This medication should be stored out of the reach of children, and it is safest to keep it in the original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The suitable storage temperature is room temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.